Kestra Advisory Services’s Annovis Bio ANVS Stock Holding History

Kestra Advisory Services’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19.7K	Buy	+10,600	New	+$20.6K	﹤0.01%	3237

Other funds holding ANVS

EAM

Empery Asset Management New York $86.5M AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Tudor Investment Corp Stamford, Connecticut $71.9B AUM 42.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Kestra Advisory Services's ANVS Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Annovis Bio (ANVS) in Q2 2026: 10,600 shares worth $19.7K. The stake represents ﹤0.01% of the portfolio and ranks #3237 among its holdings.

61 funds tracked by Wall St. Rank hold ANVS as of Q2 2026.

Kestra Advisory Services held 10,600 shares of Annovis Bio worth $19.7K as of Q2 2026.
Annovis Bio was a new Kestra Advisory Services position in Q2 2026.
Annovis Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3237 holding.
61 funds tracked by Wall St. Rank held Annovis Bio as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.